As of Feb 27
| +0.301 / +31.72%|
The 2 analysts offering 12-month price forecasts for Aveo Pharmaceuticals Inc have a median target of 1.50, with a high estimate of 2.00 and a low estimate of 1.00. The median estimate represents a +20.00% increase from the last price of 1.25.
The current consensus among 2 polled investment analysts is to Sell stock in Aveo Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.